Article info

Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis

Authors

  1. Correspondence to Dr Moshe C Ornstein; ornstem{at}ccf.org
View Full Text

Citation

Tzeng A, Tzeng TH, Ornstein MC
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis

Publication history

  • Accepted August 31, 2021
  • First published October 1, 2021.
Online issue publication 
October 01, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.